Light Street Capital Management LLC Cuts Position in Cellebrite DI Ltd. $CLBT

Light Street Capital Management LLC decreased its stake in Cellebrite DI Ltd. (NASDAQ:CLBT) by 35.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 357,755 shares of the company’s stock after selling 195,000 shares during the period. Cellebrite DI makes up 1.1% of Light Street Capital Management LLC’s investment portfolio, making the stock its 20th largest holding. Light Street Capital Management LLC owned 0.15% of Cellebrite DI worth $6,629,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Cellebrite DI by 16.8% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 173,013 shares of the company’s stock worth $3,362,000 after buying an additional 24,881 shares during the period. PNC Financial Services Group Inc. boosted its stake in shares of Cellebrite DI by 1,998.0% during the 2nd quarter. PNC Financial Services Group Inc. now owns 2,098 shares of the company’s stock worth $34,000 after acquiring an additional 1,998 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Cellebrite DI by 16.2% during the 2nd quarter. Geode Capital Management LLC now owns 314,440 shares of the company’s stock worth $5,029,000 after acquiring an additional 43,898 shares in the last quarter. Police & Firemen s Retirement System of New Jersey grew its holdings in shares of Cellebrite DI by 9.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 23,633 shares of the company’s stock worth $378,000 after acquiring an additional 2,101 shares during the period. Finally, TD Waterhouse Canada Inc. grew its holdings in shares of Cellebrite DI by 7.6% in the 2nd quarter. TD Waterhouse Canada Inc. now owns 52,977 shares of the company’s stock worth $838,000 after acquiring an additional 3,753 shares during the period. Hedge funds and other institutional investors own 45.88% of the company’s stock.

Cellebrite DI Price Performance

Shares of CLBT opened at $14.40 on Tuesday. The firm has a 50 day simple moving average of $15.19 and a 200-day simple moving average of $16.89. Cellebrite DI Ltd. has a 1-year low of $11.76 and a 1-year high of $20.86. The stock has a market cap of $3.59 billion, a price-to-earnings ratio of 46.45, a price-to-earnings-growth ratio of 2.21 and a beta of 1.30.

Cellebrite DI (NASDAQ:CLBT) last posted its earnings results on Wednesday, February 11th. The company reported $0.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.14. The firm had revenue of $128.82 million for the quarter, compared to analyst estimates of $126.07 million. Cellebrite DI had a return on equity of 20.43% and a net margin of 16.47%.Cellebrite DI’s revenue was up 28.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.10 EPS. On average, equities analysts expect that Cellebrite DI Ltd. will post 0.3 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CLBT. Wall Street Zen raised Cellebrite DI from a “sell” rating to a “hold” rating in a report on Sunday. Weiss Ratings reissued a “sell (d-)” rating on shares of Cellebrite DI in a report on Monday, December 29th. Finally, Needham & Company LLC dropped their price target on Cellebrite DI from $24.00 to $18.00 and set a “buy” rating for the company in a research report on Thursday, February 12th. Four analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Cellebrite DI currently has an average rating of “Moderate Buy” and a consensus target price of $22.50.

Cellebrite DI Profile

Cellebrite DI is a global provider of digital intelligence and forensics solutions that enable law enforcement agencies, government bodies and enterprises to extract, analyze and act on data from mobile devices, cloud services and digital sources. The company’s technology is designed to accelerate investigations, support evidence-based decision-making and enhance security operations by delivering actionable intelligence in a secure, scalable platform.

The company’s flagship offerings include the Universal Forensic Extraction Device (UFED) series for data acquisition and decoding, Physical Analyzer for advanced data parsing and visualization, and Pathfinder for case-driven investigation workflows.